Mind to Market: Technology Transfer from Academics to Capitalists Produces Biotech Bonanza
Mind to Market: Technology Transfer from Academics to Capitalists Produces Biotech Bonanza
SUGAR LAND--February 24, 2010--Researched by Industrial Info Resources (Sugar Land, Texas)--Biotechnology is a word that is frequently heard, yet is often misunderstood. Many lay people associate and interchange "biotechnology" with "pharmaceuticals," as the term "pharma-biotech" is used as an umbrella moniker for anything that we understand to be a treatment for what ails us. Although some biotechnology discoveries do become pharmaceuticals, this is not always their ultimate fate. In a nutshell, biotechnology is the use of living things to manufacture products. A more robust definition would be that biotechnology refers to techniques used by scientists to modify deoxyribonucleic acid (DNA) or the genetic material of a microorganism, plant, or animal in order to achieve a desired trait.
Companies featured: Roche Group (OTC:RHHBY)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects